Pharmacyclics

Pharmacyclics is committed to the development and commercialization of new therapies aimed at improving quality of life and prolonging survival, addressing significant unmet medical needs for cancer patients. Pharmacyclics is a wholly-owned subsidiary of AbbVie, a global research-based biopharmaceutical company.